Health Care Distributors

Agape ATP

Agape ATP released FY2026 Q1 earnings on May 15 (EST), actual revenue USD 273.66K, actual EPS USD -0.33

Agape ATP released FY2025 annual earnings on April 13, 2026 (EST), actual revenue USD 1.524 M, actual EPS USD -2.8458

Agape ATP released FY2025 Q4 earnings on April 13 Post-Market (EST), actual revenue USD 399.13 K, actual EPS USD -0.3758

Agape ATP Company Explains Stock Price Fluctuations and Commits to Transparency

Agape ATP released FY2025 9 Months Earnings on November 13 (EST), actual revenue USD 1.125M, actual EPS USD -0.0967

Agape ATP released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 370.59K, actual EPS USD -0.5867

Agape ATP released FY2025 Semi-Annual Earnings on August 13 (EST), with actual revenue of USD 754.54K and EPS of USD -2.1988

Agape ATP released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 465.5K, actual EPS USD -0.617

Agape ATP Partners with Multiple Companies to Advance Energy Transition

Agape ATP released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 289.04 K, actual EPS USD -0.0726

Agape ATP Corporation Signs $24 Billion Aviation Fuel Supply Agreement with Swiss One Oil & Gas AG

Agape ATP released FY2024 Annual Earnings on March 31 (EST), actual revenue USD 1.323 M, actual EPS USD -31.7378

Agape ATP released FY2024 Q4 earnings on March 31, 2025 (EST), actual revenue USD 359.78K, actual EPS USD -10.1318

Agape ATP Successfully Completes $23 Million Private Financing to Enhance Financial Strength

Agape ATP released FY2024 9 Months Earnings on November 14 (EST), actual revenue USD 962.97K, actual EPS USD -0.4306

Agape ATP released FY2024 Q3 earnings on November 14 (EST), actual revenue USD 331.29 K, actual EPS USD -6.5655

Agape ATP released FY2024 Q2 earnings on August 14 (EST), actual revenue USD 313.04K, actual EPS USD -5.7515

Agape ATP released FY2024 Semi-Annual earnings on August 14 (EST), actual revenue USD 631.68K, actual EPS USD -0.2993

Agape ATP released FY2024 Q1 earnings on May 14 (EST), actual revenue USD 318.64K, actual EPS USD -0.1843

Agape ATP released FY2023 Annual Earnings on April 1, 2024 (EST), Actual Revenue: USD 1.431 M, Actual EPS: USD -27.7251

PicoCELA

Co-Diagnostics

Tradr 2X Long RGTI Daily ETF

Defiance Daily Target 2X Long RGTI ETF

Tradr 2X Long QBTS Daily ETF

Netcapital

Akanda

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Liminatus Pharma

ATPC

Agape ATP (ATPC) stock surged 68.9% on Thursday without any news, attracting significant trading volume of over 20 million shares compared to its average of 43,000. Despite this spike, ATPC has struggled with its public listing and has fallen 60.75% year-to-date. Analysts suggest a consensus of 'Sell' for the stock, indicating caution for potential investors.

Tip Ranks

Why Is Penny Stock Agape ATP (ATPC) Up Today?

SDEV

GELS

PHGE

In Wednesday's after-market session, Liminatus Pharma (LIMN) surged 24.1% to $0.23, while BiomX (PHGE) rose 12.33% to $0.67. Jupiter Neurosciences (JUNS) and Stablecoin Development (SDEV) also saw gains of 12.19% and 11.18%, respectively. Conversely, HCW Biologics (HCWB) fell 15.6% to $2.05, and MetaVia (MTVA) dropped 9.0% to $2.63. Other notable losers included INVO Fertility (IVF) and Gelteq (GELS) with declines of 7.74% and 7.72%.

benzinga_article

Stablecoin Development

Gelteq

BiomX

INVO Fertility

Jupiter Neurosciences

HCW Biologics

MetaVia

First Trust NYSE Arca Biotech Index Fd

iShares US Pharma

iShares Global Healthcare

ALPS Medical Breakthrough

VG Health

Health Care Select Sector SPDR

iShares Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

SPDR S&P Health Equip

SPDR S&P Biotech

iShares US Medical Devices

Invesco Biotechnology & Genome ETF

iShares US Healthcare Providers

SPDR S&P Health

VanEck Biotech ETF

Direxion S&P Biotech Bull 3X

Alps

Longeveron

Silexion Therapeutics

Nanobiotix SA

LIMINATUS PHARMA INC C/WTS 30/04/2030 (TO PUR COM)

ALPS GROUP INC C/WTS (TO PUR ORD)

SILEXION THERAPEUTICS CORP C/WTS EXP 15/08/2029 (TO PUR COM)

12 Health Care Stocks Moving In Wednesday's After-Market Session

Agape ATP reported a revenue of $1.524 million for the year, marking a 15.2% increase year-over-year, despite a net loss of $2.308 million, which improved by 7.2% from the previous year. The gross profit was approximately $0.838 million, with a gross margin of 55.0%. The revenue growth was driven by a strategic shift towards wellness and green energy initiatives, with wellness product revenue increasing by 949% and green energy operations growing by 226.7%.

TradingView

Agape ATP 10-K: Revenue $1.52M; Net loss $2.31M

Earnings Watch

Agape ATP | 10-K: FY2025 Revenue: USD 1.524 M

Agape ATP Delays Annual 10-K Filing

Agape ATP Delays Annual 10-K Filing

Agape ATP fell 17.29%; McKesson fell 0.60%, with a transaction volume of USD 277 million; Cencora rose 0.57%, with a transaction volume of USD 161 million; Cardinal Health rose 1.37%, with a transaction volume of USD 8.555 million; Henry Schein rose 0.08%, with a market value of USD 8.346 billion

Price Alert

U.S. stock market midday update: Agape ATP down 17.29%, trading volume increased, market sentiment fluctuations attract attention

ASTC

ITRM

MKDW

In the past hour, the overall market in the U.S. stock market has shown significant divergence, with technology stocks and small-cap stocks performing particularly well. Astrotech's surge of 167.93% has attracted widespread attention in the market, driving the activity of related technology stocks. Meanwhile, several stocks in the pharmaceutical sector have also performed well, with Iterum Therap and MKD Tech rising by 106.74% and 60.08%, respectively, and their trading volumes significantly increasing, indicating strong capital interest. In contrast, some green energy and financial stocks have faced considerable pressure, with Roma Green Finance dropping sharply by 58.57%, reflecting market sentiment fluctuations. The stock with the largest movement in the past hour, Astrotech, saw its price soar to 167.93% in a short period, reaching a new 60-day high, with market sentiment running high and noticeable capital inflow. The strong performance of this stock seems to have attracted a large amount of short-term capital, energizing the entire technology sector. Strong stocks: 1. Iterum Therap: up 106.74%, with increased trading volume, driven by optimistic market sentiment about its future prospects, leading to a rapid rise in stock price. 2. MKD Tech: up 60.08%, with an influx of short-term capital making the stock stand out during the session, attracting the attention of many investors. 3. Greenland Energy: up 52.26%, this stock has been favored by the market against the backdrop of energy transition, with significantly increased trading volume

Astrotech

Iterum Therap

MKD Tech

Roma Green Finance

Greenland Energy

Urban-Gro

EpicQuest Edu

Quantum Biopharma

Southland

DNA X

OceanPal

System1

Lantern Pharma

Ridgetech

Mangoceuticals

Next Tech

Robin Energy - WI

Sobr Safe

Fast Track

High-Trend

Innovate

Turbo Energy SA

22nd Century

TruGolf

Cognition Therapeutics

Polaryx Therapeutics

Shuttle Pharmaceuticals

United Therap

MMTEC

Paranovus ENT Tech

Applied Optoelectronics

U Power

Swarmer

Founder

Boxlight

Jinxin Tech

Delixy

Abits

Luda Tech

Jaguar Uranium

Aeries Tech

AEON Biopharma, Inc.

Sysco

MOUNTAIN LAKE ACQUISITION CORP COM USD0.0001 CL A (SUB/RIGHTS) 15/11/28

FGI Industries

Century Aluminum

Beachbody

Rani Therapeutics

Chanson

Alcoa

NextTrip

Trio Petroleum

Enigmatig

SUNation Energy

Falcon Beyond Global

Kopin

Solo Brands

Opendoor Tech Series K - CW26

Veritone

Robinhood Ventures Fund I

Corvex

Bloom Energy

Newsmax

PRF Tech

Insight Molecular Diagnostics

Boqii

ImageneBio

Cibus

Globavend

ENvue Medical

Axe Compute

Origin Agritech

Carvana

Texxon

Applied Digital

Fabrinet

Streamex

ImmunityBio

EON Resources

ITERUM THERAPEUTICS PLC

U.S. stock market movement update: Astrotech surged 167.93%, Iterum Therap rose 106.74%, with multiple stocks experiencing increased trading volume; Roma Green Finance fell 58.57%, and Skycorp Solar dropped 45.70%!

ARKG

In Friday's trading session, Artelo Biosciences (NASDAQ:ARTL) saw a significant gain of 433.9%, reaching $17.03, while Polaryx Therapeutics (NASDAQ:PLYX) rose 30.56% to $8.33. Other gainers included Agape ATP (NASDAQ:ATPC) up 25.11%, Universe Pharmaceuticals (NASDAQ:UPC) up 22.22%, and MiNK Therapeutics (NASDAQ:INKT) up 18.69%. Conversely, Iterum Therapeutics (NASDAQ:ITRM) plummeted 78.1% to $0.04, followed by XORTX Therapeutics (NASDAQ:XRTX) down 77.98%. Iridex (NASDAQ:IRIX) and Cognition Therapeutics (NASDAQ:CGTX) also reported declines of 27.59% and 26.85%, respectively.

MiNK Therapeutics

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

Artelo Biosciences

Universe Pharmaceuticals

XORTX Therapeutics

12 Health Care Stocks Moving In Friday's Intraday Session

In Thursday's intraday session, several health care stocks experienced significant movements. Notable gainers included Bristol-Myers Squibb (up 34.2% to $0.14), Codexis (up 33.85% to $1.7), and Agape ATP (up 23.5% to $5.15). Conversely, Incannex Healthcare saw a decline of 38.0% to $3.7, while Acurx Pharmaceuticals fell 24.38% to $4.56. Other notable losers included Rapid Micro Biosystems (down 21.58% to $3.44) and Polaryx Therapeutics (down 20.49% to $4.58).

Agape ATP(ATPC.US)

Why Is Penny Stock Agape ATP (ATPC) Up Today?

12 Health Care Stocks Moving In Wednesday's After-Market Session

Agape ATP 10-K: Revenue $1.52M; Net loss $2.31M

Agape ATP | 10-K: FY2025 Revenue: USD 1.524 M

Agape ATP Delays Annual 10-K Filing

U.S. stock market midday update: Agape ATP down 17.29%, trading volume increased, market sentiment fluctuations attract attention

U.S. stock market movement update: Astrotech surged 167.93%, Iterum Therap rose 106.74%, with multiple stocks experiencing increased trading volume; Roma Green Finance fell 58.57%, and Skycorp Solar dropped 45.70%!

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Thursday's Intraday Session